Global Atherosclerosis Drug Market was valued at US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2026, at a 2.52% CAGR of around XX% during a forecast period. Atherosclerosis is a disease in which plaque builds up inside arteries, which leads to thicken ing, hardening, and loss of elasticity of the walls of the arteries. The atherosclerosis drug is u sed with diet to reduce complications in arteries and cure the disease. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different r egions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decis ion makers to prepare the outline for short term and long term strategies for companies by r egion.
To know about the Research Methodology :- Request Free Sample Report The scope of the report includes a detailed study of global and regional markets for atherosc lerosis drug with the reasons given for variants in the growth of the industry in certain region s. The market growth is attributed to an upsurge in the aging population and enhancement i n frequency of heart attacks due to atherosclerosis. Similarly, Obesity, unhealthy diets, and c hanges in lifestyles are factors leading to cardiovascular diseases. In addition, availability of new remedial approaches are drive global atherosclerosis drug market. Government particip ation has also played an important role in raising concerns and creating awareness about ca rdiovascular disease, improving the quality of healthcare services and infrastructure, which h as been encouraging pharmaceutical companies to develop effective drugs for the treatmen t of various diseases. These factors are projected to boost the global atherosclerosis drug m arket. However, dependence on symptom-based therapy in numerous cases, inefficiency an d adverse effects (increased incidence of diabetes and hemorrhagic stroke) of drugs existin